Table 1. Demographics of Respondents, Academic Activities, and Clinical Research Experience (n = 360).

From: Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

Number (%)
Years after graduation from medical school, n (%)
 ≤5 years 20 (5.6)
 6 to 15 years 137 (38.1)
 16 to 25 years 112 (31.1)
 ≥26 years 91 (25.3)
Satisfied with the current research support 154 (42.8)
Presentations at academic conferences as a first presenter in the previous year, n (%)
 None 42 (11.7)
 1 or 2 presentations 144 (40.0)
 3 or 4 presentations 100 (27.8)
 5 to 9 presentations 65 (18.1)
 ≥10 presentations 9 (2.5)
Publications in academic journals in the previous year, n (%)
 None 99 (27.5)
 1 or 2 publications 118 (32.8)
 3 or 4 publications 60 (16.7)
 5 to 9 publications 50 (13.9)
 ≥10 publications 33 (9.2)
Experience in clinical research
 None, n (%) 68 (18.9)
 Any experience in leading clinical research, n (%) 292 (81.1)
  Types of clinical research*
   Case report or case series report, n (%) 237 (65.8)
   Single-institute retrospective observational study, n (%) 228 (63.3)
   Single-institute prospective observational study, n (%) 82 (22.8)
   Multi-institute retrospective observational study, n (%) 82 (22.8)
   Single-institute interventional study, n (%) 55 (15.3)
   Multi-institute prospective observational study, n (%) 53 (14.7)
   Multi-institute interventional study, n (%) 38 (10.6)
   Systematic review, n (%) 22 (6.1)
Table 2. Barriers to Academic Activities, Such as Presentations at Academic Conferences and Publications in Academic Journals* (n = 360).

From: Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

n (%)
Statistical analysis 271 (75.3)
Research funding 185 (51.4)
English editing 155 (43.1)
Database creation 127 (35.3)
Ethics committee 106 (29.4)
Drafting of study protocol 98 (27.2)
Literature review 83 (23.1)
Identification of clinical questions 83 (23.1)
Data collection 75 (20.8)
Defining of research questions 66 (18.3)
Creation of tables and figures 36 (10.0)
Others 32 (8.9)
Table 3. Supports that Would Promote Academic Activities* (n = 360).

From: Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

n (%)
Support for conducting statistical analysis 193 (53.6)
Study design consultations 145 (40.3)
Support to obtain research grants 119 (33.1)
English editing 107 (29.7)
Support for statistical analysis planning 67 (18.6)
Support for ethics committee application 57 (15.8)
Support for study protocol development 56 (15.6)
Educational lectures 50 (13.9)
Support for data collection 49 (13.6)
Support for patient registration 38 (10.6)
Support for literature review 36 (10.0)
Practical training using educational materials and software 25 (6.9)
Support for the development of patient information sheet and informed consent form 21 (5.8)
Support for intellectual property and collaborative research 14 (3.9)
Support for pharmaceutical affairs 10 (2.8)
Others 21 (5.8)
Table 4. Relationship between Participants’ Perceptions of Supports that Promote Academic Activities and Years after Graduation from Medical School.

From: Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

≤5 years
(n = 20)
6 to 15 years
(n = 137)
16 to 25 years
(n = 112)
≥26 years
(n = 91)
p
Support for conducting statistical analysis, n (%) 4 (20.0) 66 (48.2) 69 (61.6) 54 (59.3) .002
Study design consultations, n (%) 8 (40.0) 61 (44.5) 47 (42.0) 29 (31.9) .275
Support to obtain research grants, n (%) 3 (15.0) 43 (31.4) 39 (34.8) 34 (37.4) .256
English editing, n (%) 6 (30.0) 47 (34.3) 33 (29.5) 21 (23.1) .343
Support for statistical analysis planning, n (%) 5 (25.0) 23 (16.8) 21 (18.8) 18 (19.8) .762
Support for ethics committee application, n (%) 1 (5.0) 18 (13.1) 22 (19.6) 16 (17.6) .288
Support for study protocol development, n (%) 4 (20.0) 13 (9.5) 19 (17.0) 20 (22.0) .050
Educational lectures, n (%) 6 (30.0) 32 (23.4) 7 (6.3) 5 (5.5) <.001
Support for data collection, n (%) 2 (10.0) 19 (13.9) 14 (12.5) 14 (15.4) .923
Support for patient registration, n (%) 3 (15.0) 16 (11.7) 14 (12.5) 5 (5.5) .251
Support for literature review, n (%) 3 (15.0) 14 (10.2) 8 (7.1) 11 (12.1) .508
Practical training using educational materials and software, n (%) 4 (20.0) 12 (8.8) 6 (5.4) 3 (3.3) .049
Support for the development of patient information sheet and informed consent form, n (%) 2 (10.0) 7 (5.1) 7 (6.3) 5 (5.5) .769
Support for intellectual property and collaborative research, n (%) 0 (0) 5 (3.6) 4 (3.6) 5 (5.5) .817
Support for pharmaceutical affairs, n (%) 0 (0) 5 (3.6) 2 (1.8) 3 (3.3) .841
Table 5. Relationship between Participants’ Perceptions of Supports that Promote Academic Activities and Participants’ Experience in Leading Clinical Trials.

From: Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

Ever led clinical trials
(n = 79)
Never led clinical trials
(n = 281)
p
Support for conducting statistical analysis, n (%) 45 (57.0) 148 (52.7) .525
Study design consultations, n (%) 23 (29.1) 122 (43.4) .027
Support to obtain research grants, n (%) 31 (39.2) 88 (31.3) .223
English editing, n (%) 19 (24.1) 88 (31.3) .265
Support for statistical analysis planning, n (%) 22 (27.8) 45 (16.0) .022
Support for ethics committee application, n (%) 14 (17.7) 43 (15.3) .603
Support for study protocol development, n (%) 20 (25.3) 36 (12.8) .013
Educational lecture, n (%) 5 (6.3) 45 (16.0) .027
Support for data collection, n (%) 11 (13.9) 38 (13.5) 1.000
Support for patient registration, n (%) 8 (10.1) 30 (10.7) 1.000
Support for literature review, n (%) 1 (1.3) 35 (12.5) .002
Practical training using educational materials and software, n (%) 3 (3.8) 22 (7.8) .316
Support for the development of patient information sheet and informed consent form, n (%) 5 (6.3) 16 (5.7) .789
Support for intellectual property and collaborative research, n (%) 5 (6.3) 9 (3.2) .200
Support for pharmaceutical affairs, n (%) 4 (5.1) 6 (2.1) .236
PAGE TOP